Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sukru Tuzmen

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|January 5, 2011
Genetic predisposition to β-thalassemia and sickle cell anemia in Turkey: a molecular diagnostic approachA Nazli Basak, Sukru Tuzmen
Methods in Molecular Biology (Clifton, N.J.)|March 3, 2007
Validation of short interfering RNA knockdowns by quantitative real-time PCRSukru Tuzmen, Jeff Kiefer, Spyro Mousses
Human Genomics|April 6, 2006
Human SNPs resulting in premature stop codons and protein truncationSevtap Savas, Sukru Tuzmen, Hilmi Ozcelik
Methods in Molecular Biology (Clifton, N.J.)|January 5, 2011
Site-directed mutagenesisPatricia E Carrigan, Petek Ballar, Sukru Tuzmen
Methods in Molecular Biology (Clifton, N.J.)|January 5, 2011
RNAi-based functional pharmacogenomicsSukru Tuzmen, Pinar Tuzmen, Shilpi Arora, et al.
Cancer Research|March 3, 2007
Intersex-like (IXL) is a cell survival regulator in pancreatic cancer with 19q13 amplificationRiina Kuuselo, Kimmo Savinainen, David O Azorsa, et al.
Human Mutation|March 12, 2008
Discovery of genetic profiles impacting response to chemotherapy: application to gemcitabineHamdi Jarjanazi, Jeffrey Kiefer, Sevtap Savas, et al.
International Journal of Cancer|May 3, 2008
Functional evidence implicating S100P in prostate cancer progressionGargi D Basu, David O Azorsa, Jeffrey A Kiefer, et al.
Plos One|April 13, 2011
NCI60 cancer cell line panel data and RNAi analysis help identify EAF2 as a modulator of simvastatin and lovastatin response in HCT-116 cellsSevtap Savas, David O Azorsa, Hamdi Jarjanazi, et al.
Breast Cancer Research and Treatment|January 26, 2010
Differential subcellular expression of protein kinase C betaII in breast cancer: correlation with breast cancer subtypesYesim Gökmen-Polar, Rutika Mehta, Sukru Tuzmen, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|January 5, 2011
Genetic predisposition to β-thalassemia and sickle cell anemia in Turkey: a molecular diagnostic approachA Nazli Basak, Sukru Tuzmen
Methods in Molecular Biology (Clifton, N.J.)|March 3, 2007
Validation of short interfering RNA knockdowns by quantitative real-time PCRSukru Tuzmen, Jeff Kiefer, Spyro Mousses
Human Genomics|April 6, 2006
Human SNPs resulting in premature stop codons and protein truncationSevtap Savas, Sukru Tuzmen, Hilmi Ozcelik
Methods in Molecular Biology (Clifton, N.J.)|January 5, 2011
Site-directed mutagenesisPatricia E Carrigan, Petek Ballar, Sukru Tuzmen
Methods in Molecular Biology (Clifton, N.J.)|January 5, 2011
RNAi-based functional pharmacogenomicsSukru Tuzmen, Pinar Tuzmen, Shilpi Arora, et al.
Cancer Research|March 3, 2007
Intersex-like (IXL) is a cell survival regulator in pancreatic cancer with 19q13 amplificationRiina Kuuselo, Kimmo Savinainen, David O Azorsa, et al.
Human Mutation|March 12, 2008
Discovery of genetic profiles impacting response to chemotherapy: application to gemcitabineHamdi Jarjanazi, Jeffrey Kiefer, Sevtap Savas, et al.
International Journal of Cancer|May 3, 2008
Functional evidence implicating S100P in prostate cancer progressionGargi D Basu, David O Azorsa, Jeffrey A Kiefer, et al.
Plos One|April 13, 2011
NCI60 cancer cell line panel data and RNAi analysis help identify EAF2 as a modulator of simvastatin and lovastatin response in HCT-116 cellsSevtap Savas, David O Azorsa, Hamdi Jarjanazi, et al.
Breast Cancer Research and Treatment|January 26, 2010
Differential subcellular expression of protein kinase C betaII in breast cancer: correlation with breast cancer subtypesYesim Gökmen-Polar, Rutika Mehta, Sukru Tuzmen, et al.
Pageof 2